Serum tissue inhibitor of metalloproteinases 1 (TIMP-1) predicts organ recovery from delayed graft function after kidney transplantation from donors after cardiac death

Cell Transplantation

Volumn 19, Issue 6-7, 2010, Pages 723-729

  Kusaka, Mamoru ^a   Kuroyanagi, Yoko ^a   Ichino, Manabu ^a   Sasaki, Hitomi ^a   Maruyama, Takahiro ^a   Hayakawa, Kunihiro ^a   Shiroki, Ryoichi ^a   Sugitani, Atsushi ^a   Kurahashi, Hiroki ^a   Hoshinaga, Kiyotaka ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Delayed graft function (DGF); Donation after cardiac death (DCD); Kidney transplantation; Tissue inhibitor of metalloproteinases 1 (TIMP 1)

Indexed keywords

BASILIXIMAB; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; ARTICLE; CLINICAL ARTICLE; DELAYED GRAFT FUNCTION; FEMALE; HEART DEATH; HUMAN; KIDNEY DONOR; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADOLESCENT; AGED; DEATH; DELAYED GRAFT FUNCTION; DIALYSIS; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; ORGAN PRESERVATION; TISSUE DONORS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; YOUNG ADULT;

EID: 77958593605     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368910X508825     Document Type: Article

References (34)

1. Ahmed, A.; Huang, L.; Raftery, A. T.; Ahmed, A. K.; Fahmy, H.; ElNahas, A. M.; Haylor, J. L. Cyclosporine A sensitizes the kidney to tubulointerstitial fibrosis induced by renal warm ischemia. Transplantation 77:686-692; 2004.
2. Bauvois, B.; Mothu, N.; Nguyen, J.; Nguyen-Khoa, T.; Nöel, L. H.; Jungers, P. Specific changes in plasma concentrations of matrix metalloproteinase-2 and -9, TIMP-1 and TGF-beta1 in patients with distinct types of primary glomerulonephritis. Nephrol. Dial. Transplant. 22:1115-1122; 2007.
3. Berthier, C. C.; Lods, N.; Joosten, S. A.; van Kooten, C.; Leppert, D.; Lindberg, R. L.; Kappeler, A.; Raulf, F.; Sterchi, E. E.; Lottaz, D.; Marti, H. P. Differential regulation of metzincins in experimental chronic renal allograft rejection: Potential markers and novel therapeutic targets. Kidney Int. 69:358-368; 2006
4. Bicknell, G. R.; Williams, S. T.; Shaw, J. A.; Pringle, J. H.; Furness, P. N.; Nicholson, M. L. Differential effects of cyclosporin and tacrolimus on the expression of fibrosis-associated genes in isolated glomeruli from renal transplants. Br. J. Surg. 87:1569-1575; 2000.
5. Boom, H.; Mallat, M. J.; de Fijter, J. W.; Zwinderman, A. H.; Paul, L. C. Delayed graft function influences renal function, but not survival. Kidney Int. 58:859-866; 2000.
6. Chromek, M.; Tullus, K.; Hertting, O.; Jaremko, G.; Khalil, A.; Li, Y. H.; Brauner, A. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in acute pyelonephritis and renal scarring. Pediatr. Res. 53:698-705; 2003
7. Daemen, J. W.; Kootstra, G.; Wijnen, R. M.; Yin, M.; Heineman, E. Nonheart-beating donors: The Maastricht experience. Clin. Transpl. 1994:303-316; 1994.
8. Endo, T.; Nakabayashi, K.; Sekiuchi, M.; Kuroda, T.; Soejima, A.; Yamada, A. Matrix metalloproteinase-2, matrix metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in the peripheral blood of patients with various glomerular diseases and their implication in pathogenetic lesions: Study based on an enzyme-linked assay and immunohistochemical staining. Clin. Exp. Nephrol. 10:253-261; $
9. Gagandeep, S.; Matsuoka, L.; Mateo, R.; Cho, Y. W.; Genyk, Y.; Sher, L.; Cicciarelli, J.; Aswad, S.; Jabbour, N.; Selby, R. Expanding the donor kidney pool: Utility of renal allografts procured in a setting of uncontrolled cardiac death. Am. J. Transplant. 6:1682-1688; 2006.
10. Giral-Classe, M.; Hourmant, M.; Cantarovich, D.; Dantal, J.; Blancho, G.; Daguin, P.; Ancelet, D.; Soulillou, J. P. Delayed graft function of more than six days strongly decreases long-term survival of transplanted kidneys. Kidney Int. 54:972-978; 1998.
11. Halloran, P. F.; Hunsicker, L. G. Delayed graft function: State of the art, November 10-11; 2000. Summit Meeting, Scottsdale, Arizona, USA. Am. J. Transplant. 1:115-120; 2001.
12. Hörstrup, J. H.; Gehrmann, M.; Schneider, B.; Plöger, A.; Froese, P.; Schirop, T.; Kampf, D.; Frei, U.; Neumann, R.; Eckardt, K. U. Elevation of serum and urine levels of TIMP-1 and tenascin in patients with renal disease. Nephrol. Dial. Transplant. 17:1005-1013; 2002.
13. Hoshinaga, K.; Shiroki, R.; Fujita, T.; Kanno, T.; Naide, Y. The fate of 359 renal allografts harvested from non-heart beating cadaver donors at a single center. Clin. Transpl. 1998:213-220; 1998.
14. Irish, W. D.; McCollum, D. A.; Tesi, R. J.; Owen, A. B.; Brennan, D. C.; Bailly, J. E.; Schnitzler, M. A. Nomogram for predicting the likelihood of delayed graft function in adult cadaveric renal transplant recipients. J. Am. Soc. Nephrol. 14:2967-2974; 2003.
15. Jain, S.; Bicknell, G. R.; Nicholson, M. L. Molecular changes in extracellular matrix turnover after renal ischaemia-reperfusion injury. Br. J. Surg. 87:1188-1192; 2000.
16. Jain, S.; Bicknell, G. R.; White, S. A.; Williams, S. T.; Furness, P. N.; Nicholson, M. L. Comparison of the expression of fibrosis-associated genes in glomeruli after renal transplantation between conventional cadaveric and non-heart-beating donors. Br. J. Surg. 86:1264-1268; 1999.
17. Kusaka, M.; Kubota, Y.; Sasaki, H.; Maruyama, T.; Hayakawa, K.; Shiroki, R.; Hoshinaga, K. Is pulsatile perfusion necessary for renal transplantation engrafting kidneys from cardiac death donors? Transplant. Proc. 38:3388-3389; 2006.
18. Kusaka, M.; Kuroyanagi, Y.; Mori, T.; Nagaoka, K.; Sasaki, H.; Maruyama,T.; Hayakawa, K.; Shiroki, R.; Kurahashi, H.; Hoshinaga, K. Serum neutrophil gelatinase-associated lipocalin as a predictor of organ recovery from delayed graft function after kidney transplantation from donors after cardiac death. Cell Transplant. 17:129-134; 2008.
19. Kusaka, M.; Kuroyanagi, Y.; Mori, T.; Nagaoka, K.; Sasaki, H.; Maruyama, T.; Hayakawa, K.; Shiroki, R.; Kurahashi, H.; Hoshinaga, K. Global expression profiles in one hour biopsy specimens of human kidney transplantation from donors after cardiac death. Cell Transplant. 18:647-656; 2009.
20. Lu, C. Y.; Penfield, J. G.; Kielar, M. L.; Vasquez, M. A.; Jeyarajah, D. R. Hypothesis: Is renal allograft rejection initiated by the response to injury sustained during the transplant process? Kidney Int. 55:2157-2168; 1999.
21. Mengel, M.; Bock, O.; Priess, M.; Haller, H.; Kreipe, H.; Gwinner, W. Expression of pro- and antifibrotic genes in protocol biopsies from renal allografts with interstitial fibrosis and tubular atrophy. Clin. Nephrol. 69:408-416; 2008.
22. Nicholson, M. L.; Metcalfe, M. S.; White, S. A.; Waller, J. R.; Doughman, T. M.; Horsburgh, T.; Feehally, J.; Carr, S. J.; Veitch, P. S. A comparison of the results of renal transplantation from non-heart-beating, conventional cadaveric, and living donors. Kidney Int. 58:2585-2591; 2000.
23. Nicholson, M. L.; Waller, J. R.; Bicknell, G. R. Renal transplant fibrosis correlates with intragraft expression of tissue inhibitor of metalloproteinase messenger RNA. Br. J. Surg. 89:933-937; 2002.
24. Pawlak, K.; Pawlak, D.; Mysliwiec, M. Serum matrix metalloproteinase-2 and increased oxidative stress are associated with carotid atherosclerosis in hemodialyzed patients. Atherosclerosis 190:199-204; 2007.
25. Prommool, S.; Jhangri, G. S.; Cockfield, S. M.; Halloran, P. F. Time dependency of factors affecting renal allograft survival. J. Am. Soc. Nephrol. 11:565-573; 2000.
26. Rached, E.; Hoffmann, D.; Blumbach, K.; Weber, K.; Dekant, W.; Mally, A. Evaluation of putative biomarkers of nephrotoxicity after exposure to ochratoxin a in vivo and in vitro. Toxicol. Sci. 103:371-381; 2008.
27. Salahudeen, A. K.; Haider, N.; May, W. Cold ischemia and the reduced long-term survival of cadaveric renal allografts. Kidney Int. 65:713-718; 2004.
28. Sayegh, M. H. Why do we reject a graft? Role of indirect allorecognition in graft rejection. Kidney Int. 65:1967-1979; 1999.
29. Tveita, A. A.; Rekvig, O. P.; Zykova, S. N. Increased glomerular matrix metalloproteinase activity in murine lupus nephritis. Kidney Int. 74:1150-1158; 2008.
30. Thomson, S. E.; McLennan, S. V.; Kirwan, P. D.; Heffernan, S. J.; Hennessy, A.; Yue, D. K.; Twigg, S. M. Renal connective tissue growth factor correlates with glomerular basement membrane thickness and prospective albuminuria in a non-human primate model of diabetes: Possible predictive marker for incipient diabetic nephropathy. J. Diabetes Complications. 22:284-294; 2008.
31. Vincenti, M. P. The matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinase (TIMP) genes. Transcriptional and posttranscriptional regulation, signal transduction and cell-type-specific expression. Methods Mol. Biol. 151:121-148; 2001.
32. Weber, M.; Dindo, D.; Demartines, N.; Ambuhl, P. M.; Clavien, P. A. Kidney transplantation from donors without a heartbeat. N. Engl. J. Med. 347:248-255; 2002.
33. Wijnen, R. M.; Booster, M. H.; Stubenitsky, B. M.; de Boer, J.; Heineman, E.; Kootstra, G. Outcome of transplantation of non-heart-beating donor kidneys. Lancet 345:1067-1070; 1995.
34. Woo, Y. M.; Jardine, A. G.; Clark, A. F.; MacGregor, M. S.; Bowman, A. W.; Macpherson, S. G.; Briggs, J. D.; Junor, B. J.; McMillan, M. A.; Rodger, R. S. Early graft function and patient survival following cadaveric renal transplantation. Kidney Int. 55:692-699; 1999.